{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:10:24Z","timestamp":1768003824957,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T00:00:00Z","timestamp":1355184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s11255-012-0347-1","type":"journal-article","created":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T11:55:51Z","timestamp":1355140551000},"page":"99-106","source":"Crossref","is-referenced-by-count":29,"title":["Preoperative prognostic factors after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma"],"prefix":"10.1007","volume":"45","author":[{"given":"Shuichi","family":"Morizane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideto","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Masago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadahiro","family":"Isoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Sejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,11]]},"reference":[{"issue":"7","key":"347_CR1","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/cncr.24147","volume":"115","author":"KA David","year":"2009","unstructured":"David KA, Mallin K, Milowsky MI, Ritchey J, Carroll PR, Nanus DM (2009) Surveillance of urothelial carcinoma: stage and grade migration, 1993\u20132005 and survival trends, 1993\u20132000. Cancer 115(7):1435\u20131447","journal-title":"Cancer"},{"issue":"9","key":"347_CR2","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1464-410X.2010.09341.x","volume":"106","author":"E Pieras","year":"2010","unstructured":"Pieras E, Frontera G, Ruiz X, Vicens A, Ozonas M, Piza P (2010) Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma. BJU Int 106(9):1319\u20131323","journal-title":"BJU Int"},{"issue":"2","key":"347_CR3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.urology.2004.09.021","volume":"65","author":"Y Matsui","year":"2005","unstructured":"Matsui Y, Utsunomiya N, Ichioka K, Ueda N, Yoshimura K, Terai A, Arai Y (2005) Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 65(2):279\u2013283","journal-title":"Urology"},{"issue":"7","key":"347_CR4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1464-410X.2005.05804.x","volume":"96","author":"JD Raman","year":"2005","unstructured":"Raman JD, Ng CK, Boorjian SA, Vaughan ED Jr, Sosa RE, Scherr DS (2005) Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology. BJU Int 96(7):1031\u20131035","journal-title":"BJU Int"},{"issue":"4","key":"347_CR5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.urolonc.2009.04.007","volume":"29","author":"JH Ku","year":"2011","unstructured":"Ku JH, Choi WS, Kwak C, Kim HH (2011) Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract. Urol Oncol 29(4):383\u2013387","journal-title":"Urol Oncol"},{"issue":"2","key":"347_CR6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.urolonc.2009.06.003","volume":"29","author":"MD Azemar","year":"2011","unstructured":"Azemar MD, Comperat E, Richard F, Cussenot O, Roupret M (2011) Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol 29(2):130\u2013136","journal-title":"Urol Oncol"},{"issue":"9","key":"347_CR7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1442-2042.2008.02114.x","volume":"15","author":"N Soga","year":"2008","unstructured":"Soga N, Arima K, Sugimura Y (2008) Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma. Int J Urol 15(9):800\u2013803","journal-title":"Int J Urol"},{"issue":"5","key":"347_CR8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1053\/j.ajkd.2007.08.007","volume":"50","author":"SD Chung","year":"2007","unstructured":"Chung SD, Huang KH, Lai MK, Huang CY, Chen CH, Pu YS, Yu HJ, Chueh SC (2007) CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma. Am J Kidney Dis 50(5):743\u2013753","journal-title":"Am J Kidney Dis"},{"key":"347_CR9","doi-asserted-by":"crossref","unstructured":"Kim KH, You D, Jeong IG, Hong JH, Ahn H, Kim CS (2012) Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma. Urol Oncol. doi: 10.1016\/j.urolonc.2012.04.014","DOI":"10.1016\/j.urolonc.2012.04.014"},{"issue":"4","key":"347_CR10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.eururo.2009.11.035","volume":"57","author":"R Zigeuner","year":"2010","unstructured":"Zigeuner R, Shariat SF, Margulis V, Karakiewicz PI, Roscigno M, Weizer A, Kikuchi E, Remzi M, Raman JD, Bolenz C, Bensalah K, Capitanio U, Koppie TM, Kassouf W, Sircar K, Patard JJ, Fernandez MI, Wood CG, Montorsi F, Strobel P, Wheat JC, Haitel A, Oya M, Guo CC, Ng C, Chade DC, Sagalowsky A, Langner C (2010) Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 57(4):575\u2013581","journal-title":"Eur Urol"},{"issue":"4","key":"347_CR11","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0090-4295(98)00295-7","volume":"52","author":"MC Hall","year":"1998","unstructured":"Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG (1998) Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52(4):594\u2013601","journal-title":"Urology"},{"issue":"4","key":"347_CR12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.eururo.2010.07.003","volume":"58","author":"RL Favaretto","year":"2010","unstructured":"Favaretto RL, Shariat SF, Chade DC, Godoy G, Adamy A, Kaag M, Bochner BH, Coleman J, Dalbagni G (2010) The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol 58(4):574\u2013580","journal-title":"Eur Urol"},{"issue":"4","key":"347_CR13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.urology.2007.06.1106","volume":"70","author":"KS Cho","year":"2007","unstructured":"Cho KS, Hong SJ, Cho NH, Choi YD (2007) Grade of hydronephrosis and tumor diameter as preoperative prognostic factors in ureteral transitional cell carcinoma. Urology 70(4):662\u2013666","journal-title":"Urology"},{"key":"347_CR14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.juro.2012.04.009","volume":"189","author":"M Rink","year":"2012","unstructured":"Rink M, Robinson BD, Green DA, Cha EK, Hansen J, Comploj E, Margulis V, Raman JD, Ng CK, Remzi M, Bensalah K, Kabbani W, Haitel A, Rioux-Leclercq N, Guo CC, Chun FK, Kikuchi E, Kassouf W, Sircar K, Sun M, Sonpavde G, Lotan Y, Pycha A, Karakiewicz PI, Scherr DS, Shariat SF (2012) Impact of Histological Variants on Clinical Outcomes of Patients with Upper Urinary Tract Urothelial Carcinoma. J Urol 189:398\u2013404","journal-title":"J Urol"},{"issue":"6","key":"347_CR15","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.eururo.2009.12.029","volume":"57","author":"G Novara","year":"2010","unstructured":"Novara G, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Bastian PJ, Martinez-Salamanca JI, Seitz C, Lemberger RJ, Burger M, El-Hakim A, Baba S, Martignoni G, Gupta A, Karakiewicz PI, Ficarra V, Shariat SF (2010) Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol 57(6):1064\u20131071","journal-title":"Eur Urol"},{"issue":"2","key":"347_CR16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.juro.2009.04.026","volume":"182","author":"WM Li","year":"2009","unstructured":"Li WM, Li CC, Ke HL, Wu WJ, Huang CN, Huang CH (2009) The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy. J Urol 182(2):451\u2013458","journal-title":"J Urol"},{"issue":"2","key":"347_CR17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1464-410X.2007.06934.x","volume":"100","author":"K Saito","year":"2007","unstructured":"Saito K, Kawakami S, Ohtsuka Y, Fujii Y, Masuda H, Kumagai J, Kobayashi T, Kageyama Y, Kihara K (2007) The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically. BJU Int 100(2):269\u2013273","journal-title":"BJU Int"},{"issue":"1","key":"347_CR18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/1097-0142(19940701)74:1<123::AID-CNCR2820740121>3.0.CO;2-T","volume":"74","author":"L Sengelov","year":"1994","unstructured":"Sengelov L, Kamby C, Schou G, von der Maase H (1994) Prognostic factors and significance of chemotherapy in patients with recurrent or metastatic transitional cell cancer of the urinary tract. Cancer 74(1):123\u2013133","journal-title":"Cancer"},{"issue":"8","key":"347_CR19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jjco\/28.8.497","volume":"28","author":"M Kuroda","year":"1998","unstructured":"Kuroda M, Kotake T, Akaza H, Hinotsu S, Kakizoe T (1998) Efficacy of dose-intensified MEC (methotrexate, epirubicin and cisplatin) chemotherapy for advanced urothelial carcinoma: a prospective randomized trial comparing MEC and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin). Jpn J Clin Oncol 28(8):497\u2013501","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"347_CR20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DW, Kurth K (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49(3):466\u2013475","journal-title":"Eur Urol"},{"issue":"1","key":"347_CR21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.ju.0000100105.27708.6c","volume":"171","author":"BJ Duggan","year":"2004","unstructured":"Duggan BJ, Gray SB, McKnight JJ, Watson CJ, Johnston SR, Williamson KE (2004) Oligoclonality in bladder cancer: the implication for molecular therapies. J Urol 171(1):419\u2013425","journal-title":"J Urol"},{"issue":"6","key":"347_CR22","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","volume":"115","author":"V Margulis","year":"2009","unstructured":"Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD, Wood CG, Upper Tract Urothelial Carcinoma CollaborationThe Upper Tract Urothelial Carcinoma C (2009) Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 115(6):1224\u20131233","journal-title":"Cancer"},{"issue":"2","key":"347_CR23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02893372","volume":"11","author":"S Bircan","year":"2005","unstructured":"Bircan S, Candir O, Kapucuoglu N (2005) The effect of tumor invasion patterns on pathologic stage of bladder urothelial carcinomas. Pathol Oncol Res 11(2):87\u201391","journal-title":"Pathol Oncol Res"},{"issue":"11","key":"347_CR24","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1200\/JCO.2009.25.4599","volume":"28","author":"J Bellmunt","year":"2010","unstructured":"Bellmunt J, Choueiri TK, Fougeray R, Schutz FA, Salhi Y, Winquist E, Culine S, von der Maase H, Vaughn DJ, Rosenberg JE (2010) Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimens. J Clin Oncol 28(11):1850\u20131855","journal-title":"J Clin Oncol"},{"issue":"8","key":"347_CR25","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1464-410X.2011.10479.x","volume":"109","author":"JI Martinez-Salamanca","year":"2012","unstructured":"Martinez-Salamanca JI, Shariat SF, Rodriguez JC, Chromecki TF, Ficarra V, Fritsche HM, Kassouf W, Matsumoto K, Cabello LO, Seitz C, Tritschler S, Walton TJ, Zattoni F, Novara G (2012) Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study. BJU Int 109(8):1155\u20131161","journal-title":"BJU Int"},{"issue":"1","key":"347_CR26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clon.2008.09.007","volume":"21","author":"D Trivanovic","year":"2009","unstructured":"Trivanovic D, Petkovic M, Stimac D (2009) New prognostic index to predict survival in patients with cancer of unknown primary site with unfavourable prognosis. Clin Oncol 21(1):43\u201348","journal-title":"Clin Oncol"},{"issue":"12","key":"347_CR27","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P","volume":"91","author":"JJ Caro","year":"2001","unstructured":"Caro JJ, Salas M, Ward A, Goss G (2001) Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 91(12):2214\u20132221","journal-title":"Cancer"},{"issue":"6","key":"347_CR28","first-page":"1151","volume":"10","author":"V Yurut-Caloglu","year":"2009","unstructured":"Yurut-Caloglu V, Caloglu M, Kaplan M, Inci O (2009) Pre-treatment hemoglobin levels are important for bladder carcinoma patients with extravesical extension undergoing definitive radiotherapy. Asian Pac J Cancer Prev 10(6):1151\u20131157","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-012-0347-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-012-0347-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-012-0347-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T11:59:09Z","timestamp":1559390349000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-012-0347-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,11]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["347"],"URL":"https:\/\/doi.org\/10.1007\/s11255-012-0347-1","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,11]]}}}